Albert Bourla, Pfizer CEO (Steven Ferdman/Getty Images)

The prospect of an Oc­to­ber OK large­ly closed, Pfiz­er's Al­bert Bourla promis­es not to sub­mit for EUA un­til No­vem­ber

For weeks in late sum­mer and ear­ly fall, Pfiz­er CEO Al­bert Bourla in­sist­ed they would like­ly know whether their vac­cine works by the end of Oc­to­ber and then “im­me­di­ate­ly” sub­mit for an FDA OK, fu­el­ing con­cerns that Pres­i­dent Trump could push through a po­lit­i­cal­ly mo­ti­vat­ed EUA on the eve of Elec­tion Day. But now, in the lat­est of a se­ries of moves that ap­peared de­signed to dis­tance his com­pa­ny from a po­ten­tial po­lit­i­cal mael­strom, Bourla has made clear they won’t go to reg­u­la­tors for about an­oth­er month.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.